Paradigm Biopharmaceuticals Ltd
ASX:PAR

Watchlist Manager
Paradigm Biopharmaceuticals Ltd Logo
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Watchlist
Price: 0.42 AUD 1.2% Market Closed
Market Cap: 163.6m AUD

Wall Street
Price Targets

PAR Price Targets Summary
Paradigm Biopharmaceuticals Ltd

Wall Street analysts forecast PAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PAR is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

Lowest
Price Target
0.81 AUD
92% Upside
Average
Price Target
0.82 AUD
94% Upside
Highest
Price Target
0.84 AUD
100% Upside
Paradigm Biopharmaceuticals Ltd Competitors:
Price Targets
RNA
Avidity Biosciences Inc
117% Upside
CDNA
CareDx Inc
46% Upside
4584
Kidswell Bio Corporation
75% Upside
NTRA
Natera Inc
28% Upside
87S
Roivant Sciences Ltd
59% Upside
VITR
Vitrolife AB
50% Upside
IVA
Inventiva SA
228% Upside
301207
Hualan Biological Bacterin Inc
13% Upside

Revenue
Forecast

Revenue Estimate
Paradigm Biopharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Paradigm Biopharmaceuticals Ltd's revenue is 21%.

21%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Paradigm Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

Net Income Estimate
Paradigm Biopharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-36%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PAR's stock price target?
Price Target
0.82 AUD

According to Wall Street analysts, the average 1-year price target for PAR is 0.82 AUD with a low forecast of 0.81 AUD and a high forecast of 0.84 AUD.

Back to Top